Review




Structured Review

NuMED Inc human dbs leads
Human Dbs Leads, supplied by NuMED Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+dbs+leads/pmc09869648-71-11-26?v=NuMED+Inc
Average 90 stars, based on 1 article reviews
human dbs leads - by Bioz Stars, 2026-07
90/100 stars

Images



Similar Products

90
NuMED Inc human dbs leads
Human Dbs Leads, supplied by NuMED Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+dbs+leads/pmc09869648-71-11-26?v=NuMED+Inc
Average 90 stars, based on 1 article reviews
human dbs leads - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
NuMED Inc human dbs leads contact height inter-contact spacing diameter
Human Dbs Leads Contact Height Inter Contact Spacing Diameter, supplied by NuMED Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+dbs+leads/us11318311-166-16-30?v=NuMED+Inc
Average 90 stars, based on 1 article reviews
human dbs leads contact height inter-contact spacing diameter - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
NuMED Inc 8-contact scaled versions human dbs leads
8 Contact Scaled Versions Human Dbs Leads, supplied by NuMED Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+dbs+leads/us10786676-165-16-30?v=NuMED+Inc
Average 90 stars, based on 1 article reviews
8-contact scaled versions human dbs leads - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
NuMED Inc 8-contact scaled-down version of human dbs leads
Location of Utah array and <t>DBS</t> leads. A, Utah arrays were placed over the arm area of the M1 (top). The image of Subject K was obtained end of study after perfusion; the image of Subject J was obtained intraoperatively. B, DBS lead locations in <t>the</t> <t>STN</t> and GPi with location of DBS leads in the STN and GPi in each subject. Contacts used for therapeutic stimulation shown in yellow. In both animals, we verified that DBS in STN and GPi contacts produced improvements in parkinsonian motor signs (Table 1). Th = thalamus, SN = substantia nigra, GPe = globus pallidus externus.
8 Contact Scaled Down Version Of Human Dbs Leads, supplied by NuMED Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+dbs+leads/pmc07055133-66-29-43?v=NuMED+Inc
Average 90 stars, based on 1 article reviews
8-contact scaled-down version of human dbs leads - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
NuMED Inc 8-contact scaled down versions of human dbs leads
The effects of parkinsonism on oscillatory activity and phase-amplitude coupling (PAC) across all recorded structures in each subject. A and E: location of Utah array in the motor cortex (M1; top) and location of deep brain stimulation <t>(DBS)</t> leads in the subthalamic nucleus and internal and external segments of the globus pallidus [subthalamic <t>nucleus</t> <t>(STN),</t> internal segment of the globus pallidus (GPi), and external segment of the globus pallidus (GPe); bottom]. In animal J, contact pairs C2–3, C3–4, and C4–5 are estimated to be in the GPi, and the most dorsal usable contact pair, C5–6, straddled the border between GPe and GPi. Also shown are PSDs (left) and PAC comodulograms (right) in the M1 (B and F), STN (C and G), and globus pallidus (GP; D and H). Power spectral density (PSD) plots reflect median values, and shaded regions contain the 25th and 75th percentiles of the PSDs at each frequency. The white dashed boxes in the PAC comodulograms indicate regions associated with an observed increase in PAC in the parkinsonian condition.
8 Contact Scaled Down Versions Of Human Dbs Leads, supplied by NuMED Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+dbs+leads/pmc05672540-73-17-31?v=NuMED+Inc
Average 90 stars, based on 1 article reviews
8-contact scaled down versions of human dbs leads - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
NuMED Inc 4-contact scaled version of a human dbs lead
Closed-loop <t>DBS</t> (CL-DBS) that <t>delivers</t> <t>STN</t> stimulation based on the level of beta activity in the STN has comparable therapeutic effect on rigidity compared to traditional DBS (tDBS) but does not improve performance on a cued reaching task. A) In the parkinsonian (MPTP) macaque used in this study, a peak (~14Hz) in the low beta range is present in the normalized power spectral density calculated from LFPs recorded from STN DBS electrode contacts 1–3. This plot was derived from LFPs recording during one of the 3 minute baseline recording sessions. B) Schematic of the system used to implement real-time CL-DBS, which incorporates Tucker Davis Technologies (TDT) hardware. LFPs were recorded from DBS contacts 1 and 3, subtracted to achieve a bipolar LFP signal and bandpass filtered (9–20Hz) to extract what we are defining as beta LFP (i). The beta amplitude envelope was calculated by rectifying and low-pass filtering by means of a 400ms moving average filter (ii). The threshold level for stimulation was fixed at the median of the beta amplitude envelope calculated from the baseline LFP recording acquired at the start of each experimental session. During CL-DBS, a trigger that was switched on/off whenever the beta amplitude was greater/less than the threshold (iii) controlled stimulation (Monopolar C2, 133Hz, 700μA, 80μs/phase, (iv)). An on/off ramp time (250ms) was employed to reduce potential paresthesias induced by switching on stimulation. C) Experiment design. Following the 3 min. baseline recording session, from which the CL-DBS trigger level was defined, an experiment block consisting of a control or stimulation (CL-DBS or tDBS) period, clinical rigidity assessment, behavior assessment, and washout; experiment blocks were repeated for each experimental condition: Off-DBS, tDBS, CL-DBS. The order of blocks was randomized each day. D) Schematic showing the cued reach behavior task. E) Rigidity scores for arm and leg joints based on blinded assessment during each condition (mean ± SE; P<0.05). F) Total movement time (left) and peak speeds during reach and return task epochs (middle,right) for each condition (mean and 95% C.I.; P<0.05). The “normal” condition reflects data collected when the animal was in the normal state before MPTP administration. G) Top: beta amplitude envelope averaged over all trials in each condition, aligned to reach onset (Time = 0 s). Bottom: DBS stimulus level (as a percentage of the maximum level) averaged over all trials in the CL-DBS condition, aligned to reach onset (Time = 0 s). a: mean reach duration, b: mean return duration
4 Contact Scaled Version Of A Human Dbs Lead, supplied by NuMED Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+dbs+leads/pmc05143196-44-37-40?v=NuMED+Inc
Average 90 stars, based on 1 article reviews
4-contact scaled version of a human dbs lead - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
NuMED Inc human dbs lead numed 2880 main st. hopkinton, ny
Closed-loop <t>DBS</t> (CL-DBS) that <t>delivers</t> <t>STN</t> stimulation based on the level of beta activity in the STN has comparable therapeutic effect on rigidity compared to traditional DBS (tDBS) but does not improve performance on a cued reaching task. A) In the parkinsonian (MPTP) macaque used in this study, a peak (~14Hz) in the low beta range is present in the normalized power spectral density calculated from LFPs recorded from STN DBS electrode contacts 1–3. This plot was derived from LFPs recording during one of the 3 minute baseline recording sessions. B) Schematic of the system used to implement real-time CL-DBS, which incorporates Tucker Davis Technologies (TDT) hardware. LFPs were recorded from DBS contacts 1 and 3, subtracted to achieve a bipolar LFP signal and bandpass filtered (9–20Hz) to extract what we are defining as beta LFP (i). The beta amplitude envelope was calculated by rectifying and low-pass filtering by means of a 400ms moving average filter (ii). The threshold level for stimulation was fixed at the median of the beta amplitude envelope calculated from the baseline LFP recording acquired at the start of each experimental session. During CL-DBS, a trigger that was switched on/off whenever the beta amplitude was greater/less than the threshold (iii) controlled stimulation (Monopolar C2, 133Hz, 700μA, 80μs/phase, (iv)). An on/off ramp time (250ms) was employed to reduce potential paresthesias induced by switching on stimulation. C) Experiment design. Following the 3 min. baseline recording session, from which the CL-DBS trigger level was defined, an experiment block consisting of a control or stimulation (CL-DBS or tDBS) period, clinical rigidity assessment, behavior assessment, and washout; experiment blocks were repeated for each experimental condition: Off-DBS, tDBS, CL-DBS. The order of blocks was randomized each day. D) Schematic showing the cued reach behavior task. E) Rigidity scores for arm and leg joints based on blinded assessment during each condition (mean ± SE; P<0.05). F) Total movement time (left) and peak speeds during reach and return task epochs (middle,right) for each condition (mean and 95% C.I.; P<0.05). The “normal” condition reflects data collected when the animal was in the normal state before MPTP administration. G) Top: beta amplitude envelope averaged over all trials in each condition, aligned to reach onset (Time = 0 s). Bottom: DBS stimulus level (as a percentage of the maximum level) averaged over all trials in the CL-DBS condition, aligned to reach onset (Time = 0 s). a: mean reach duration, b: mean return duration
Human Dbs Lead Numed 2880 Main St. Hopkinton, Ny, supplied by NuMED Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+dbs+leads/pmc05039463-266-6-9?v=NuMED+Inc
Average 90 stars, based on 1 article reviews
human dbs lead numed 2880 main st. hopkinton, ny - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
NuMED Inc scaled-down version of a human dbs lead (2f diameter, 8 annular electrode contacts: height, spacing)
Model geometry and FEM. (A) The geometry of the fiber pathways in the PPTg area in relation to the <t>DBS</t> <t>lead</t> location. CTG, central tegmental tract—orange; ON, oculomotor nerve—purple; SCP, superior cerebellar peduncle—red; MLF, medial longitudinal fasciculus—blue; ML, medial lemniscus—green; LL, lateral lemniscus—yellow; PPTg, pedunculopontine tegmental nucleus—gray. (B) Sagittal view of the geometry of the modeled fiber pathways. (C) The FEM geometry, showing the lead location and grounded chamber. (D) Electric potential isosurfaces for the anisotropic and isotropic model.
Scaled Down Version Of A Human Dbs Lead (2f Diameter, 8 Annular Electrode Contacts: Height, Spacing), supplied by NuMED Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+dbs+leads/pmc04500924-125-36-51?v=NuMED+Inc
Average 90 stars, based on 1 article reviews
scaled-down version of a human dbs lead (2f diameter, 8 annular electrode contacts: height, spacing) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Location of Utah array and DBS leads. A, Utah arrays were placed over the arm area of the M1 (top). The image of Subject K was obtained end of study after perfusion; the image of Subject J was obtained intraoperatively. B, DBS lead locations in the STN and GPi with location of DBS leads in the STN and GPi in each subject. Contacts used for therapeutic stimulation shown in yellow. In both animals, we verified that DBS in STN and GPi contacts produced improvements in parkinsonian motor signs (Table 1). Th = thalamus, SN = substantia nigra, GPe = globus pallidus externus.

Journal: The Journal of Neuroscience

Article Title: Direct Activation of Primary Motor Cortex during Subthalamic But Not Pallidal Deep Brain Stimulation

doi: 10.1523/JNEUROSCI.2480-19.2020

Figure Lengend Snippet: Location of Utah array and DBS leads. A, Utah arrays were placed over the arm area of the M1 (top). The image of Subject K was obtained end of study after perfusion; the image of Subject J was obtained intraoperatively. B, DBS lead locations in the STN and GPi with location of DBS leads in the STN and GPi in each subject. Contacts used for therapeutic stimulation shown in yellow. In both animals, we verified that DBS in STN and GPi contacts produced improvements in parkinsonian motor signs (Table 1). Th = thalamus, SN = substantia nigra, GPe = globus pallidus externus.

Article Snippet: Briefly, the location of the target nuclei was confirmed using extracellular microelectrode mapping and each animal was implanted targeting the STN and GPi with an 8-contact scaled-down version of human DBS leads (0.5 mm contact height, 0.5 mm inter-contact spacing, 0.625 mm diameter; NuMed).

Techniques: Produced

Improvement in parkinsonian motor signs during acute  STN  and GPi  DBS

Journal: The Journal of Neuroscience

Article Title: Direct Activation of Primary Motor Cortex during Subthalamic But Not Pallidal Deep Brain Stimulation

doi: 10.1523/JNEUROSCI.2480-19.2020

Figure Lengend Snippet: Improvement in parkinsonian motor signs during acute STN and GPi DBS

Article Snippet: Briefly, the location of the target nuclei was confirmed using extracellular microelectrode mapping and each animal was implanted targeting the STN and GPi with an 8-contact scaled-down version of human DBS leads (0.5 mm contact height, 0.5 mm inter-contact spacing, 0.625 mm diameter; NuMed).

Techniques:

M1 single-unit responses to acute STN and GPi DBS. A, Example recording traces from two channels at the onset of STN DBS. Channel 17 had two isolated cells: 17a decreased firing rate and 17b increased firing rate. Channel 75 had one isolated cell with antidromic firing response. B, Examples of peristimulus time raster plots aligned to DBS (or sham) pulses before, during, and after STN DBS illustrating the four main response categories based on firing rate and pattern: antidromic, suppression, excitation, and no change. C, Examples of peristimulus time raster plots demonstrating suppression, excitation, and no change responses before, during, and after GPi DBS. Antidromic activation of M1 was not observed with GPi DBS. D, Normalized peristimulus time histograms (firing rate relative to the mean pre-DBS period) are shown, illustrating the four response classifications used in this study. E, Pie charts illustrating the percentage of each response type in M1 during acute STN (left) and GPi DBS (right) for each animal. Antidromic firing in M1 was only observed during STN DBS, and in greater proportion in Subject K than in Subject J, whereas similar proportions of excitation and suppression were observed for each animal for either STN or GPi DBS.

Journal: The Journal of Neuroscience

Article Title: Direct Activation of Primary Motor Cortex during Subthalamic But Not Pallidal Deep Brain Stimulation

doi: 10.1523/JNEUROSCI.2480-19.2020

Figure Lengend Snippet: M1 single-unit responses to acute STN and GPi DBS. A, Example recording traces from two channels at the onset of STN DBS. Channel 17 had two isolated cells: 17a decreased firing rate and 17b increased firing rate. Channel 75 had one isolated cell with antidromic firing response. B, Examples of peristimulus time raster plots aligned to DBS (or sham) pulses before, during, and after STN DBS illustrating the four main response categories based on firing rate and pattern: antidromic, suppression, excitation, and no change. C, Examples of peristimulus time raster plots demonstrating suppression, excitation, and no change responses before, during, and after GPi DBS. Antidromic activation of M1 was not observed with GPi DBS. D, Normalized peristimulus time histograms (firing rate relative to the mean pre-DBS period) are shown, illustrating the four response classifications used in this study. E, Pie charts illustrating the percentage of each response type in M1 during acute STN (left) and GPi DBS (right) for each animal. Antidromic firing in M1 was only observed during STN DBS, and in greater proportion in Subject K than in Subject J, whereas similar proportions of excitation and suppression were observed for each animal for either STN or GPi DBS.

Article Snippet: Briefly, the location of the target nuclei was confirmed using extracellular microelectrode mapping and each animal was implanted targeting the STN and GPi with an 8-contact scaled-down version of human DBS leads (0.5 mm contact height, 0.5 mm inter-contact spacing, 0.625 mm diameter; NuMed).

Techniques: Isolation, Activation Assay

Strength of antidromic firing in M1 diminishes over time. A, Heat map illustrating the time course of the population PSTH of M1 cells that were antidromically activated during the first 50 s of STN DBS for both subjects. Before averaging, the PSTH of each cell was aligned to the time bin in the PSTH where firing was maximal, and firing rate normalized to the firing rate calculated over the first three time bins. Zero on the x-axis represents the time point of peak antidromic firing. PSTH were calculated in 2 s bins and for visualization a 5-point linear interpolation both x and y axes was performed. B, The percentage of cells with significant change in their peak PSTH firing rate [first 10 s vs the last 10 s, Wilcoxon rank sum (WRS) test, p < 0.05]. C, Time course of the population PSTH of cells whose responses to 15 and 80 Hz stimulation were tested in addition to 130 Hz.

Journal: The Journal of Neuroscience

Article Title: Direct Activation of Primary Motor Cortex during Subthalamic But Not Pallidal Deep Brain Stimulation

doi: 10.1523/JNEUROSCI.2480-19.2020

Figure Lengend Snippet: Strength of antidromic firing in M1 diminishes over time. A, Heat map illustrating the time course of the population PSTH of M1 cells that were antidromically activated during the first 50 s of STN DBS for both subjects. Before averaging, the PSTH of each cell was aligned to the time bin in the PSTH where firing was maximal, and firing rate normalized to the firing rate calculated over the first three time bins. Zero on the x-axis represents the time point of peak antidromic firing. PSTH were calculated in 2 s bins and for visualization a 5-point linear interpolation both x and y axes was performed. B, The percentage of cells with significant change in their peak PSTH firing rate [first 10 s vs the last 10 s, Wilcoxon rank sum (WRS) test, p < 0.05]. C, Time course of the population PSTH of cells whose responses to 15 and 80 Hz stimulation were tested in addition to 130 Hz.

Article Snippet: Briefly, the location of the target nuclei was confirmed using extracellular microelectrode mapping and each animal was implanted targeting the STN and GPi with an 8-contact scaled-down version of human DBS leads (0.5 mm contact height, 0.5 mm inter-contact spacing, 0.625 mm diameter; NuMed).

Techniques:

The strength of antidromic activation of M1 cells was progressively diminished over 4 h of continuous STN. A, C, Composite scores based on the mUPDRS (y-axis) for Subjects K and J, respectively. X-axis represents the time of stimulation. mUPDRS scores are shown for Hours 1–3 but were not taken in Hour 4. Detailed scores for individual motor signs are presented in Table 2. B, D, Time course of cell population PSTH over 4 h of STN DBS in each animal is shown in the heat map (left). The percentage of cells with significant change in their peak PSTH firing rate [DBS onset vs 4 h DBS duration, Wilcoxon rank sum (WRS) test, p < 0.05] is shown in the pie charts (right). PSTH were calculated in 2 s bins and grouped into DBS onset (first 50 s of recording) and 1, 2, 3, and 4 h DBS time bins. Before averaging, the PSTH of each cell was aligned to the time bin in the PSTH where firing was maximal, and firing rate normalized to the firing rate calculated over the first three time bins.

Journal: The Journal of Neuroscience

Article Title: Direct Activation of Primary Motor Cortex during Subthalamic But Not Pallidal Deep Brain Stimulation

doi: 10.1523/JNEUROSCI.2480-19.2020

Figure Lengend Snippet: The strength of antidromic activation of M1 cells was progressively diminished over 4 h of continuous STN. A, C, Composite scores based on the mUPDRS (y-axis) for Subjects K and J, respectively. X-axis represents the time of stimulation. mUPDRS scores are shown for Hours 1–3 but were not taken in Hour 4. Detailed scores for individual motor signs are presented in Table 2. B, D, Time course of cell population PSTH over 4 h of STN DBS in each animal is shown in the heat map (left). The percentage of cells with significant change in their peak PSTH firing rate [DBS onset vs 4 h DBS duration, Wilcoxon rank sum (WRS) test, p < 0.05] is shown in the pie charts (right). PSTH were calculated in 2 s bins and grouped into DBS onset (first 50 s of recording) and 1, 2, 3, and 4 h DBS time bins. Before averaging, the PSTH of each cell was aligned to the time bin in the PSTH where firing was maximal, and firing rate normalized to the firing rate calculated over the first three time bins.

Article Snippet: Briefly, the location of the target nuclei was confirmed using extracellular microelectrode mapping and each animal was implanted targeting the STN and GPi with an 8-contact scaled-down version of human DBS leads (0.5 mm contact height, 0.5 mm inter-contact spacing, 0.625 mm diameter; NuMed).

Techniques: Activation Assay

Clinical ratings of parkinsonian animals before, during and after subacute  STN   DBS

Journal: The Journal of Neuroscience

Article Title: Direct Activation of Primary Motor Cortex during Subthalamic But Not Pallidal Deep Brain Stimulation

doi: 10.1523/JNEUROSCI.2480-19.2020

Figure Lengend Snippet: Clinical ratings of parkinsonian animals before, during and after subacute STN DBS

Article Snippet: Briefly, the location of the target nuclei was confirmed using extracellular microelectrode mapping and each animal was implanted targeting the STN and GPi with an 8-contact scaled-down version of human DBS leads (0.5 mm contact height, 0.5 mm inter-contact spacing, 0.625 mm diameter; NuMed).

Techniques:

Interspike interval (ISI) probability histograms illustrate that antidromic-classified cells had highly regular discharge patterns during DBS. A, Spike occurrences during STN DBS in two M1 cells from Subject K are shown in the top (2.5 s duration segment shown, each row = 0.5 s). Corresponding ISI probability histograms from the entire recording block are shown in the bottom, with Off-DBS ISI histograms shown for comparison. Prominent peaks corresponding to one and two times the DBS stimulation interstimulus period (∼7.7 ms) are evident. B, ISI probability histograms from 15 simultaneously recorded cells identified as antidromic (Subject K) displayed as a heat map. C, Proportion of antidromic-classified cells in subacute DBS sessions with ISI probability peaks at one or two times the DBS ISI (or other) based on recordings at early (<0.5 h on-DBS) and late (3–4 h on-DBS) in the on-DBS recording period.

Journal: The Journal of Neuroscience

Article Title: Direct Activation of Primary Motor Cortex during Subthalamic But Not Pallidal Deep Brain Stimulation

doi: 10.1523/JNEUROSCI.2480-19.2020

Figure Lengend Snippet: Interspike interval (ISI) probability histograms illustrate that antidromic-classified cells had highly regular discharge patterns during DBS. A, Spike occurrences during STN DBS in two M1 cells from Subject K are shown in the top (2.5 s duration segment shown, each row = 0.5 s). Corresponding ISI probability histograms from the entire recording block are shown in the bottom, with Off-DBS ISI histograms shown for comparison. Prominent peaks corresponding to one and two times the DBS stimulation interstimulus period (∼7.7 ms) are evident. B, ISI probability histograms from 15 simultaneously recorded cells identified as antidromic (Subject K) displayed as a heat map. C, Proportion of antidromic-classified cells in subacute DBS sessions with ISI probability peaks at one or two times the DBS ISI (or other) based on recordings at early (<0.5 h on-DBS) and late (3–4 h on-DBS) in the on-DBS recording period.

Article Snippet: Briefly, the location of the target nuclei was confirmed using extracellular microelectrode mapping and each animal was implanted targeting the STN and GPi with an 8-contact scaled-down version of human DBS leads (0.5 mm contact height, 0.5 mm inter-contact spacing, 0.625 mm diameter; NuMed).

Techniques: Blocking Assay, Comparison

Synchronization in populational unit activities decreased with therapeutic STN DBS. A, Spike synchronization scores for all simultaneously recorded M1 cells across multiple 4 h STN DBS stimulation days (color coded) in both animals are shown as mean ± SD. Results of one-way ANOVA test for each session are shown in the tables (top). Following a significant one-way ANOVA test result, Dunnett's test with control = PRE (*p < 0.05) was performed for the sessions that had awake rest data in the PRE-DBS condition (2 for Subject K and 5 for Subject J), showing significant reduction of spike synchronization during STN DBS in each day. B, Combined spike synchronization scores (mean ± SD) from all the stimulation days that had the PRE-DBS condition are reduced during therapeutic STN DBS for both NHPs (mixed-model ANOVA, Subject K: F(6,9966) = 5.2, p = 0.028, 2 d; Subject J: F(6,22780) = 8.1, p < 0.0001, 5 d; followed by Dunnett's test with control = PRE (*p < 0.05). The combined spike synchronization scores for the first and second hours post-DBS returned to the pre-DBS level (Dunnett's test with control = PRE, p > 0.05).

Journal: The Journal of Neuroscience

Article Title: Direct Activation of Primary Motor Cortex during Subthalamic But Not Pallidal Deep Brain Stimulation

doi: 10.1523/JNEUROSCI.2480-19.2020

Figure Lengend Snippet: Synchronization in populational unit activities decreased with therapeutic STN DBS. A, Spike synchronization scores for all simultaneously recorded M1 cells across multiple 4 h STN DBS stimulation days (color coded) in both animals are shown as mean ± SD. Results of one-way ANOVA test for each session are shown in the tables (top). Following a significant one-way ANOVA test result, Dunnett's test with control = PRE (*p < 0.05) was performed for the sessions that had awake rest data in the PRE-DBS condition (2 for Subject K and 5 for Subject J), showing significant reduction of spike synchronization during STN DBS in each day. B, Combined spike synchronization scores (mean ± SD) from all the stimulation days that had the PRE-DBS condition are reduced during therapeutic STN DBS for both NHPs (mixed-model ANOVA, Subject K: F(6,9966) = 5.2, p = 0.028, 2 d; Subject J: F(6,22780) = 8.1, p < 0.0001, 5 d; followed by Dunnett's test with control = PRE (*p < 0.05). The combined spike synchronization scores for the first and second hours post-DBS returned to the pre-DBS level (Dunnett's test with control = PRE, p > 0.05).

Article Snippet: Briefly, the location of the target nuclei was confirmed using extracellular microelectrode mapping and each animal was implanted targeting the STN and GPi with an 8-contact scaled-down version of human DBS leads (0.5 mm contact height, 0.5 mm inter-contact spacing, 0.625 mm diameter; NuMed).

Techniques: Control

Pairwise spike synchronization of simultaneously recorded unit activities pre, during and post-therapeutic STN DBS in both NHPs. A, Averaged matrix illustration of the pattern of cell–cell synchronization changes with STN DBS from the first stimulation day in each animal. Matrices were generated based on the synchronization score calculated for each pair of cells. Fourteen (of 54) and four (of 30) antidromic classified neurons were identified in Subjects K and J, respectively, in these examples. Different pairs including antidromic to antidromic (Anti–Anti), antidromic to non-antidromic (Anti–NonAnti), non-antidromic to non-antidromic (NonAnti–NonAnti) neurons are labeled as shown in the left matrix pattern. B, Pairwise spike synchronization from all the stimulation days that had awake rest data in the PRE-DBS condition (2 for Subject K and 5 for Subject J) for different groups (Anti–Anti, Anti–NonAnti and NonAnti–NonAnti) are shown. Anti–NonAnti pairwise spike synchronization was reduced by STN DBS in both subjects, whereas NonAnti–NonAnti spike synchronization was only reduced in Subject K. Anti-Anti spike synchronization did not change except for an increase at the first hour on STN DBS in Subject K. Wilcoxon test followed by Steel's test with control = PRE. *p < 0.05. C, Proportion of cell pairs with increased or decreased cell–cell spike synchronization scores, comparing pre-DBS period to fourth hour on-DBS, in all cell pairs (top) and in different groups (bottom).

Journal: The Journal of Neuroscience

Article Title: Direct Activation of Primary Motor Cortex during Subthalamic But Not Pallidal Deep Brain Stimulation

doi: 10.1523/JNEUROSCI.2480-19.2020

Figure Lengend Snippet: Pairwise spike synchronization of simultaneously recorded unit activities pre, during and post-therapeutic STN DBS in both NHPs. A, Averaged matrix illustration of the pattern of cell–cell synchronization changes with STN DBS from the first stimulation day in each animal. Matrices were generated based on the synchronization score calculated for each pair of cells. Fourteen (of 54) and four (of 30) antidromic classified neurons were identified in Subjects K and J, respectively, in these examples. Different pairs including antidromic to antidromic (Anti–Anti), antidromic to non-antidromic (Anti–NonAnti), non-antidromic to non-antidromic (NonAnti–NonAnti) neurons are labeled as shown in the left matrix pattern. B, Pairwise spike synchronization from all the stimulation days that had awake rest data in the PRE-DBS condition (2 for Subject K and 5 for Subject J) for different groups (Anti–Anti, Anti–NonAnti and NonAnti–NonAnti) are shown. Anti–NonAnti pairwise spike synchronization was reduced by STN DBS in both subjects, whereas NonAnti–NonAnti spike synchronization was only reduced in Subject K. Anti-Anti spike synchronization did not change except for an increase at the first hour on STN DBS in Subject K. Wilcoxon test followed by Steel's test with control = PRE. *p < 0.05. C, Proportion of cell pairs with increased or decreased cell–cell spike synchronization scores, comparing pre-DBS period to fourth hour on-DBS, in all cell pairs (top) and in different groups (bottom).

Article Snippet: Briefly, the location of the target nuclei was confirmed using extracellular microelectrode mapping and each animal was implanted targeting the STN and GPi with an 8-contact scaled-down version of human DBS leads (0.5 mm contact height, 0.5 mm inter-contact spacing, 0.625 mm diameter; NuMed).

Techniques: Generated, Labeling, Control

The effects of parkinsonism on oscillatory activity and phase-amplitude coupling (PAC) across all recorded structures in each subject. A and E: location of Utah array in the motor cortex (M1; top) and location of deep brain stimulation (DBS) leads in the subthalamic nucleus and internal and external segments of the globus pallidus [subthalamic nucleus (STN), internal segment of the globus pallidus (GPi), and external segment of the globus pallidus (GPe); bottom]. In animal J, contact pairs C2–3, C3–4, and C4–5 are estimated to be in the GPi, and the most dorsal usable contact pair, C5–6, straddled the border between GPe and GPi. Also shown are PSDs (left) and PAC comodulograms (right) in the M1 (B and F), STN (C and G), and globus pallidus (GP; D and H). Power spectral density (PSD) plots reflect median values, and shaded regions contain the 25th and 75th percentiles of the PSDs at each frequency. The white dashed boxes in the PAC comodulograms indicate regions associated with an observed increase in PAC in the parkinsonian condition.

Journal: Journal of Neurophysiology

Article Title: Parkinsonism and vigilance: alteration in neural oscillatory activity and phase-amplitude coupling in the basal ganglia and motor cortex

doi: 10.1152/jn.00388.2017

Figure Lengend Snippet: The effects of parkinsonism on oscillatory activity and phase-amplitude coupling (PAC) across all recorded structures in each subject. A and E: location of Utah array in the motor cortex (M1; top) and location of deep brain stimulation (DBS) leads in the subthalamic nucleus and internal and external segments of the globus pallidus [subthalamic nucleus (STN), internal segment of the globus pallidus (GPi), and external segment of the globus pallidus (GPe); bottom]. In animal J, contact pairs C2–3, C3–4, and C4–5 are estimated to be in the GPi, and the most dorsal usable contact pair, C5–6, straddled the border between GPe and GPi. Also shown are PSDs (left) and PAC comodulograms (right) in the M1 (B and F), STN (C and G), and globus pallidus (GP; D and H). Power spectral density (PSD) plots reflect median values, and shaded regions contain the 25th and 75th percentiles of the PSDs at each frequency. The white dashed boxes in the PAC comodulograms indicate regions associated with an observed increase in PAC in the parkinsonian condition.

Article Snippet: Each animal was then implanted in both the STN and GP with 8-contact scaled down versions of human DBS leads (0.5 mm contact height, 0.5 mm intercontact spacing, 0.625 mm diameter; NuMED).

Techniques: Activity Assay

Closed-loop DBS (CL-DBS) that delivers STN stimulation based on the level of beta activity in the STN has comparable therapeutic effect on rigidity compared to traditional DBS (tDBS) but does not improve performance on a cued reaching task. A) In the parkinsonian (MPTP) macaque used in this study, a peak (~14Hz) in the low beta range is present in the normalized power spectral density calculated from LFPs recorded from STN DBS electrode contacts 1–3. This plot was derived from LFPs recording during one of the 3 minute baseline recording sessions. B) Schematic of the system used to implement real-time CL-DBS, which incorporates Tucker Davis Technologies (TDT) hardware. LFPs were recorded from DBS contacts 1 and 3, subtracted to achieve a bipolar LFP signal and bandpass filtered (9–20Hz) to extract what we are defining as beta LFP (i). The beta amplitude envelope was calculated by rectifying and low-pass filtering by means of a 400ms moving average filter (ii). The threshold level for stimulation was fixed at the median of the beta amplitude envelope calculated from the baseline LFP recording acquired at the start of each experimental session. During CL-DBS, a trigger that was switched on/off whenever the beta amplitude was greater/less than the threshold (iii) controlled stimulation (Monopolar C2, 133Hz, 700μA, 80μs/phase, (iv)). An on/off ramp time (250ms) was employed to reduce potential paresthesias induced by switching on stimulation. C) Experiment design. Following the 3 min. baseline recording session, from which the CL-DBS trigger level was defined, an experiment block consisting of a control or stimulation (CL-DBS or tDBS) period, clinical rigidity assessment, behavior assessment, and washout; experiment blocks were repeated for each experimental condition: Off-DBS, tDBS, CL-DBS. The order of blocks was randomized each day. D) Schematic showing the cued reach behavior task. E) Rigidity scores for arm and leg joints based on blinded assessment during each condition (mean ± SE; P<0.05). F) Total movement time (left) and peak speeds during reach and return task epochs (middle,right) for each condition (mean and 95% C.I.; P<0.05). The “normal” condition reflects data collected when the animal was in the normal state before MPTP administration. G) Top: beta amplitude envelope averaged over all trials in each condition, aligned to reach onset (Time = 0 s). Bottom: DBS stimulus level (as a percentage of the maximum level) averaged over all trials in the CL-DBS condition, aligned to reach onset (Time = 0 s). a: mean reach duration, b: mean return duration

Journal: Brain stimulation

Article Title: Closed-loop deep brain stimulation effects on parkinsonian motor symptoms in a non-human primate -- is beta enough?

doi: 10.1016/j.brs.2016.06.051

Figure Lengend Snippet: Closed-loop DBS (CL-DBS) that delivers STN stimulation based on the level of beta activity in the STN has comparable therapeutic effect on rigidity compared to traditional DBS (tDBS) but does not improve performance on a cued reaching task. A) In the parkinsonian (MPTP) macaque used in this study, a peak (~14Hz) in the low beta range is present in the normalized power spectral density calculated from LFPs recorded from STN DBS electrode contacts 1–3. This plot was derived from LFPs recording during one of the 3 minute baseline recording sessions. B) Schematic of the system used to implement real-time CL-DBS, which incorporates Tucker Davis Technologies (TDT) hardware. LFPs were recorded from DBS contacts 1 and 3, subtracted to achieve a bipolar LFP signal and bandpass filtered (9–20Hz) to extract what we are defining as beta LFP (i). The beta amplitude envelope was calculated by rectifying and low-pass filtering by means of a 400ms moving average filter (ii). The threshold level for stimulation was fixed at the median of the beta amplitude envelope calculated from the baseline LFP recording acquired at the start of each experimental session. During CL-DBS, a trigger that was switched on/off whenever the beta amplitude was greater/less than the threshold (iii) controlled stimulation (Monopolar C2, 133Hz, 700μA, 80μs/phase, (iv)). An on/off ramp time (250ms) was employed to reduce potential paresthesias induced by switching on stimulation. C) Experiment design. Following the 3 min. baseline recording session, from which the CL-DBS trigger level was defined, an experiment block consisting of a control or stimulation (CL-DBS or tDBS) period, clinical rigidity assessment, behavior assessment, and washout; experiment blocks were repeated for each experimental condition: Off-DBS, tDBS, CL-DBS. The order of blocks was randomized each day. D) Schematic showing the cued reach behavior task. E) Rigidity scores for arm and leg joints based on blinded assessment during each condition (mean ± SE; P<0.05). F) Total movement time (left) and peak speeds during reach and return task epochs (middle,right) for each condition (mean and 95% C.I.; P<0.05). The “normal” condition reflects data collected when the animal was in the normal state before MPTP administration. G) Top: beta amplitude envelope averaged over all trials in each condition, aligned to reach onset (Time = 0 s). Bottom: DBS stimulus level (as a percentage of the maximum level) averaged over all trials in the CL-DBS condition, aligned to reach onset (Time = 0 s). a: mean reach duration, b: mean return duration

Article Snippet: Data were collected from one female rhesus macaque (25 yr.) rendered parkinsonian by two intra-carotid and two systemic injections of the neurotoxin 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) and implanted in the STN with a 4-contact scaled version of a human DBS lead (NuMed) using standard approaches described elsewhere [ 19 ].

Techniques: Activity Assay, Derivative Assay, Blocking Assay, Control

Model geometry and FEM. (A) The geometry of the fiber pathways in the PPTg area in relation to the DBS lead location. CTG, central tegmental tract—orange; ON, oculomotor nerve—purple; SCP, superior cerebellar peduncle—red; MLF, medial longitudinal fasciculus—blue; ML, medial lemniscus—green; LL, lateral lemniscus—yellow; PPTg, pedunculopontine tegmental nucleus—gray. (B) Sagittal view of the geometry of the modeled fiber pathways. (C) The FEM geometry, showing the lead location and grounded chamber. (D) Electric potential isosurfaces for the anisotropic and isotropic model.

Journal: Frontiers in Computational Neuroscience

Article Title: Subject-specific computational modeling of DBS in the PPTg area

doi: 10.3389/fncom.2015.00093

Figure Lengend Snippet: Model geometry and FEM. (A) The geometry of the fiber pathways in the PPTg area in relation to the DBS lead location. CTG, central tegmental tract—orange; ON, oculomotor nerve—purple; SCP, superior cerebellar peduncle—red; MLF, medial longitudinal fasciculus—blue; ML, medial lemniscus—green; LL, lateral lemniscus—yellow; PPTg, pedunculopontine tegmental nucleus—gray. (B) Sagittal view of the geometry of the modeled fiber pathways. (C) The FEM geometry, showing the lead location and grounded chamber. (D) Electric potential isosurfaces for the anisotropic and isotropic model.

Article Snippet: The high-field imaging, along with results from electrophysiological microelectrode mapping of the PPTg area, were superimposed in Monkey Cicerone (Miocinovic et al., ) to define a trajectory for unilateral implantation of a scaled-down version of a human DBS lead (2F diameter, 8 annular electrode contacts: 0.5 mm height, 0.25 mm spacing) (NuMed, Hopkinton, NY) in the region of the PPTg (right hemisphere).

Techniques: